Scientists Restore Sleep in Mice with Alzheimer's

Researchers have found that overactive immune cells in the brain contribute to sleep loss in Alzheimer's disease. Temporarily removing these cells in mice restored more than two hours of sleep per day.
Researchers have made a discovery about sleep loss in Alzheimer's disease. They found that the brain's own immune cells play a role in the sleep disturbances associated with the condition. In mice with amyloid plaques, overactive microglia triggered inflammation that disrupted deep, restorative sleep. This inflammation kept the brain from getting enough sleep. The researchers then temporarily removed most of these microglia cells from the mice. As a result, the mice got more than two hours of additional sleep per day. Notably, the amyloid plaques in the mice remained unchanged, suggesting that the sleep restoration was not due to the removal of the plaques themselves. The study's findings provide new insights into the relationship between immune cells, inflammation, and sleep in Alzheimer's disease. The discovery could potentially lead to new treatments for sleep disturbances in people with Alzheimer's. The researchers' work highlights the complex interplay between different factors in the development of Alzheimer's symptoms.
Go Deeper
What triggered sleep loss in the mice with Alzheimer's?
Overactive microglia, which are the brain's immune cells, triggered inflammation that disrupted deep, restorative sleep. This inflammation kept the brain from getting enough sleep.
How much sleep was restored in the mice?
More than two hours of sleep per day was restored in the mice after the microglia cells were temporarily removed.
Did the removal of microglia cells affect the amyloid plaques?
No, the amyloid plaques in the mice remained unchanged after the microglia cells were removed. The sleep restoration was not due to the removal of the plaques themselves.
What could this discovery lead to?
The discovery could potentially lead to new treatments for sleep disturbances in people with Alzheimer's disease. It provides new insights into the relationship between immune cells, inflammation, and sleep in Alzheimer's disease.
What is the significance of this study's findings?
The study's findings highlight the complex interplay between different factors in the development of Alzheimer's symptoms. They suggest that targeting immune cells and inflammation could be a new approach to addressing sleep disturbances in Alzheimer's disease.
More health
Medicare Drug Plan Deductible Limit Rises to $700 in 2027; Enrollment Ends December 7
Medicare's standard drug coverage numbers rise in 2027, with the deductible limit moving to $700 and the yearly out-of-pocket cap to $2,400, though wh
Nov 14health50+4.3 Million People Must Replace a Medicare Plan That Ends This Year
KFF, using federal plan files, says 4.3 million people will lose a Medicare Advantage drug plan or a stand-alone drug plan at the end of 2026. Open en
Nov 12health50+Study Links a Common Bone Medicine to a Lower Dementia Risk
Research from the University of Hong Kong, shared widely by ScienceDaily on November 9, found that older adults with weak bones who took a common bone
Nov 11